SUBOXONE
SUBOXONE
Approved
DIN Number
02502321
Drug Class
Human
Market Date
Jun 17, 2021
Company
HC
INDIVIOR UK LIMITED
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02502321
AIG Number0252216005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N07BC51 BUPRENORPHINE, COMBINATIONS
Product Specifications
Dosage FormFilm, Soluble
Route of AdministrationSublingual
,
Buccal
AHFS Classification28:08.12
Health Canada Classification
ACTIVE INGREDIENTS (2)
BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE)Active
Strength: 4 MG
Monograph: BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE)
NALOXONE (NALOXONE HYDROCHLORIDE)Active
Strength: 1 MG
Monograph: NALOXONE (NALOXONE HYDROCHLORIDE)